DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
162.33
+5.99 (3.83%)
Nov 20, 2026, 2:38 PM EST - Market open
DaVita Revenue
DaVita had revenue of $3.58B in the quarter ending September 30, 2026, with 4.62% growth. This brings the company's total for the last twelve months to $14.17B, up 6.38% year-over-year. In the year 2025, DaVita had annual revenue of $13.64B with 6.46% growth. That makes DaVita the 1,084th largest company in the world by revenue and 355th in the United States.
Revenue (ttm)
$14.17B
Revenue Growth
+6.38%
P/S Ratio
0.72
Revenue / Employee
$181,635
Employees
78,000
Market Cap
10.21B
Revenue by Segment
- US Dialysis 11.73B 86.0%
- Other - Ancillary Dialysis 1.91B 14.0%
Fiscal year ended Dec 31, 2025 See the full DaVita breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.64B | 827.52M | 6.46% |
| Dec 31, 2024 | 12.82B | 675.40M | 5.56% |
| Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
| Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
| Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
| Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
| Dec 31, 2019 | 11.39B | -16.37M | -0.14% |
| Dec 31, 2018 | 11.40B | 528.22M | 4.86% |
| Dec 31, 2017 | 10.88B | 169.17M | 1.58% |
| Dec 31, 2016 | 10.71B | 725.22M | 7.27% |
| Dec 31, 2015 | 9.98B | -2.81B | -21.98% |
| Dec 31, 2014 | 12.80B | 1.03B | 8.76% |
| Dec 31, 2013 | 11.76B | 3.58B | 43.70% |
| Dec 31, 2012 | 8.19B | 1.45B | 21.61% |
| Dec 31, 2011 | 6.73B | 512.20M | 8.24% |
| Dec 31, 2010 | 6.22B | 118.96M | 1.95% |
| Dec 31, 2009 | 6.10B | 440.48M | 7.78% |
| Dec 31, 2008 | 5.66B | 396.02M | 7.52% |
| Dec 31, 2007 | 5.26B | 383.49M | 7.86% |
| Dec 31, 2006 | 4.88B | 1.91B | 64.12% |
| Dec 31, 2005 | 2.97B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tenet Healthcare | 22.15B |
| Fresenius Medical Care AG | 22.12B |
| Universal Health Services | 18.35B |
| Encompass Health | 6.34B |
| Option Care Health | 5.75B |
| PACS Group | 5.71B |
| The Ensign Group | 5.67B |
| Surgery Partners | 3.36B |
DVA News
- 3 days ago - DaVita Expands Availability of Advanced Dialysis Therapy to Every U.S. Center - PRNewsWire
- 8 days ago - DVA Investors Have Opportunity to Join DaVita Inc. Fraud Investigation with SBS Law - Business Wire
- 10 days ago - DaVita Transcript: 8th Annual Wolfe Research Healthcare Conference - Transcripts
- 10 days ago - Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws - GlobeNewsWire
- 11 days ago - DaVita Transcript: UBS Global Healthcare Conference - Transcripts
- 16 days ago - Did You Lose Money on DaVita Inc. Stock? The Law Offices of Howard G. - Business Wire
- 16 days ago - DaVita Inc. to Participate in Upcoming Investor Conferences - PRNewsWire
- 17 days ago - Lost Money on DaVita Inc. Shares? The Law Offices of Frank R. - Business Wire